Health
Newly identified biomarker could predict response to immune checkpoint inhibitors – News-Medical.net
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI)…
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.
“Although ICIs revolutionized…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence